https://finance.yahoo.com/news/axsome-therapeutics-announces-fda-approval-104500101.html
0
0
Axsome Therapeutics Announces FDA Approval of AUVELITY™, the First and Only Oral NMDA Receptor Antagonist for the Treatment of Major Depressive Disorder in Adults - Yahoo Finance
8/19/22 at 10:45am
Organization
Yahoo Entertainment
Authors
Axsome Therapeutics Inc.
48 words
0
Comments
AUVELITY is the first and only rapid-acting oral treatment approved with labeling of statistically significant improvement in depressive symptoms compared to...
You are the first to view
Create an account or login to join the discussion